Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer

Oral Oncology

Volumn 48, Issue 10, 2012, Pages 1051-1057

  Merlano, Marco C ^a   Monteverde, Martino ^a   Colantonio, Ida ^a   Denaro, Nerina ^a,c   Lo Nigro, Cristiana ^a   Natoli, Guido ^a   Giurlanda, Francesco ^a   Numico, Gianmauro ^b   Russi, Elvio ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b Aosta Hospital   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Age; Chemoradiation toxicity; Head and neck cancer

Indexed keywords

CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; PACLITAXEL; PROTEIN P53;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CANCER; HUMAN; INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NEUTROPENIA; NEUTROPHIL COUNT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION PNEUMONIA; RADIATION SAFETY; STOMATITIS; THROMBOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION;

AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866357582     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.05.001     Document Type: Article

References (13)

1. S.P. Schantz, and G.P. Yu Head and neck cancer incidence trends in young Americans, 1937-1997, with a special analysis for tongue cancer Arch Otolaryngol Head Neck Surg 128 2002 268 274
2. J.-P. Pignon, J. Bourhis, and C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data Lancet 255 2000 949 955
3. J.-P. Pignon, A. Maitre, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
4. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
5. L. Repetto, L. Fratino, and R.A. Audisio Comprehensive geriatric assessment adds information to eastern cooperative oncology group performance status in elderly cancer patients: an Italian group for geriatric oncology study J Clin Oncol 20 2 2002 Jan 15 494 502
6. D. Bergamaschi, M. Gasco, and L. Hiller P53 polymorphism influences response in cancer chemotherapy via modulation of p73 - dependent apoptosis Can Cell 3 2003 387 402
7. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer New Engl J Med 350 2004 1945 1952
8. Paclitaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy. Personal data, unpublished.
9. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck New Engl J Med 354 2006 567 578
10. M. Merlano, V. Vitale, and R. Rosso Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy New Engl J Med 327 1992 1115 1121
11. O. Ekberg Videofluoroscopy in elderly patients with aspiration: importance of evaluating both oral and pharyngeal stages of deglutition AJR 156 1991 293 296
12. B.G. Haffty Concurrent chemoradiation in the treatment of head and neck cancer Hemathol Oncol Clin North Am 13 1999 719 742
13. J.L. Lefebvre, F. Rolland, and M. Tesselaar Phase 3 randomized trial of larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy J Natl Can Inst 101 2009 142 152